Physician profile
Thomas P Vail
NPI 1598852014
$5,680,170.68
in general payments reported to CMS, 2019-2025
6 companies · $1.1M in 2025
The $1.1M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $745K · 2020: $633K · 2021: $780K · 2022: $941K · 2023: $731K · 2024: $772K · 2025: $1.1M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.6M · Consulting Fee: $23K · Travel and Lodging: $1,422 · Food and Beverage: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,557,205.77 |
| Consulting Fee | $23,040.00 |
| Travel and Lodging | $1,421.99 |
| Food and Beverage | $139.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $5,605,738.98 | 2019-2025 | Attune, Emphasys |
| Medical Device Business Services, INC. | $72,822.48 | 2019-2023 | |
| Ethicon INC. | $1,440.00 | 2020 | |
| Depuy Synthes Sales INC. | $121.25 | 2019 | |
| Stryker Corporation | $30.77 | 2019 | |
| Janssen Research & Development, LLC | $17.20 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Vail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.